# The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma

> **NCT03242824** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 21 (actual)

## Conditions studied

- Glioma

## Interventions

- **DRUG:** Fluorine F 18 Fluorodopa
- **RADIATION:** Intensity-Modulated Radiation Therapy
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT03242824
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-29
- **Primary completion:** 2020-06-16
- **Final completion:** 2021-06-16
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2023-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03242824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03242824, "The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03242824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*